{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:42:40Z","timestamp":1759405360720,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021778","name":"Agencia Nacional De Promoci\u00f3n Cient\u00edfica Y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2017-2484"],"award-info":[{"award-number":["PICT-2017-2484"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.076","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T01:06:39Z","timestamp":1683248799000},"page":"3534-3543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties"],"prefix":"10.1016","volume":"41","author":[{"given":"Cecilia","family":"Czibener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Armando","family":"Rey Serantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis Mariano","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina Alejandra","family":"Pasquevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Cassataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Jos\u00e9","family":"Comerci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Esteban","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.076_b0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.076_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-animal-021815-111326","article-title":"Virulence factors and immunity","volume":"4","author":"Byndloss","year":"2016","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.vaccine.2023.04.076_b0015","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.04.076_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.925773","article-title":"Evaluation of brucellosis vaccines: a comprehensive review","volume":"9","author":"Heidary","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2023.04.076_b0025","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2016.09.004","article-title":"Vaccination with a DeltanorD DeltaznuA Brucella abortus mutant confers potent protection against virulent challenge","volume":"34","author":"Yang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.076_b0030","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.71.11.6264-6269.2003","article-title":"Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine","volume":"71","author":"Ugalde","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.04.076_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.vaccine.2015.11.030","article-title":"Brucella abortus DeltacydCDeltacydD and DeltacydCDeltapurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus","volume":"34","author":"Truong","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.076_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molimm.2017.10.011","article-title":"Deletion of the transcriptional regulator GntR down regulated the expression of Genes Related to Virulence and Conferred Protection against Wild-Type Brucella Challenge in BALB\/c Mice","volume":"92","author":"Li","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.micpath.2018.08.052","article-title":"Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant","volume":"124","author":"Li","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2023.04.076_b0050","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses","volume":"79","author":"Clapp","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.04.076_b0055","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/IAI.05330-11","article-title":"Protective efficacy and safety of Brucella melitensis 16MDeltamucR against intraperitoneal and aerosol challenge in BALB\/c mice","volume":"79","author":"Arenas-Gamboa","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.04.076_b0060","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.vaccine.2016.02.025","article-title":"Delta-pgm, a new live-attenuated vaccine against Brucella suis","volume":"34","author":"Czibener","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.076_b0065","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/CVI.00191-15","article-title":"Protection provided by an encapsulated live attenuated DeltaabcBA strain of Brucella ovis against experimental challenge in a murine model","volume":"22","author":"Silva","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1297-9716-45-61","article-title":"Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection","volume":"45","author":"Sancho","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2023.04.076_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0378-1135(02)00231-6","article-title":"Control of small ruminant brucellosis by use of Brucella melitensis Rev. 1 vaccine: laboratory aspects and field observations","volume":"90","author":"Banai","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/jb.66.5.600-605.1953","article-title":"Immunization against brucella infection. II. Effectiveness of a streptomycin-dependent strain of Brucella melitensis","volume":"66","author":"Herzberg","year":"1953","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1128\/jb.66.5.585-599.1953","article-title":"Immunization against brucella infection. I. Isolation and characterization of a streptomycin-dependent mutant","volume":"66","author":"Herzberg","year":"1953","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0090","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/IAI.68.10.5716-5723.2000","article-title":"Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication","volume":"68","author":"Ugalde","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.04.076_b0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-2427(94)05361-U","article-title":"Improved competitive enzyme immunoassay for the diagnosis of bovine brucellosis","volume":"46","author":"Nielsen","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0100","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1128\/JB.180.17.4392-4400.1998","article-title":"Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1\u20132) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants","volume":"180","author":"Inon de Iannino","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.vetmic.2014.04.014","article-title":"A bacterial engineered glycoprotein as a novel antigen for diagnosis of bovine brucellosis","volume":"172","author":"Ciocchini","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2023.04.076_b0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.micinf.2019.05.002","article-title":"Direct correlation between Th1 and Th17 responses in immunity to Brucella infection","volume":"21","author":"Rahmanpour","year":"2019","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.04.076_b0115","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","article-title":"The advances in brucellosis vaccines","volume":"37","author":"Hou","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.04.076_b0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-5877(96)01110-5","article-title":"A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats","volume":"31","author":"Blasco","year":"1997","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.vaccine.2023.04.076_b0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2105\/AJPH.77.3.335","article-title":"An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers","volume":"77","author":"Olle-Goig","year":"1987","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2023.04.076_b0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0140-6736(93)91571-3","article-title":"Brucella melitensis Rev-1 vaccine as a cause of human brucellosis","volume":"342","author":"Blasco","year":"1993","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300511X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300511X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:36Z","timestamp":1759404456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2300511X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X2300511X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}